Cathy Jenkins
Chief Financial Officer
Replay available
Sagicor Financial Company Ltd. (TSX: SFC) Q1 2026 earnings conference call, held 2026-05-15. Replay captured from the company's public earnings webcast.

Chief Financial Officer
Analyst, Scotiabank
Analyst, National Bank
EVP, Corporate Development and Capital Markets
Analyst, RBC Capital Markets
Analyst, Acumen
President and Chief Executive Officer
music music Thank you. Thank you. Thank you. Thank you. Good morning, my name is Ina and I will be your conference operator today. At this time, I would like to welcome everyone to SagiCorp Financial Company's first quarter 2026 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star, then the number one on your telephone keypad. If you would like to withdraw your question, please press star, then the number two. Thank you. Mr. George Sipsis, EVP, Corporate Development and Capital Markets, you may begin your conference. Great. Thank you, Operator. And hello, everyone. Thank you for joining us today to discuss Sagicor's first quarter 2026 results. Our disclosures are available on our investor relations website at investors.sagicor.com, which include a press release, financial statements, MD&A, and the supplemental information package containing core earnings, drivers of earnings, and additional disclosures. The link to our live webcast is also available on our website. This conference call is open to the financial community, investors, the media, and the public with a reminder that the Q&A period is reserved for financial research analysts. I will begin by referring you to the cautionary language and disclaimers in our materials and public filings regarding the use of forward-looking statements and the use of non-IFRS financial measures and ratios, which may be mentioned as part of our remarks today. I would also like to remind the audience that the actual results regarding forward-looking information could differ materially And please note that a detailed discussion of Sagicor's risk factors is pr...